Our Capabilities

Pramand’s portfolio of proprietary hydrogel technology and our team’s decades of developing and commercializing hydrogel-based medical devices positions us to be the leader in creating new hydrogel based medical devices to address unmet medical needs in a range of surgical interventions.

Our Impact

Our Capabilities

Our team has launched over ten medical device companies based on hydrogel technology which have generated over $4B in value and exits and helped over 5 million patients worldwide achieve better outcomes.

Portfolio Companies

Hydrogel implant for minimizing intrauterine adhesions (IUAs)

Dural sealant to provide watertight dural closure following craniotomy

Hemostatic sealant patch for controlling moderate surgical bleeding

www.rejoni.com

Hemostatic sealant patch for controlling moderate surgical bleeding

Dural sealant to provide watertight dural closure following craniotomy

Hemostatic sealant patch for controlling moderate surgical bleeding

www.sealonix.com

Our Capabilities

Our Capabilities

Our Capabilities

Our Impact

Our Capabilities

Our Capabilities

Portfolio Companies

Hydrogel implant for minimizing intrauterine adhesions (IUAs)

Dural sealant to provide watertight dural closure following craniotomy

Hemostatic sealant patch for controlling moderate surgical bleeding

Hemostatic sealant patch for controlling moderate surgical bleeding

Dural sealant to provide watertight dural closure following craniotomy

Hemostatic sealant patch for controlling moderate surgical bleeding

Dural sealant to provide watertight dural closure following craniotomy

Dural sealant to provide watertight dural closure following craniotomy

Dural sealant to provide watertight dural closure following craniotomy

Recent News

This website uses cookies.